世界の自己免疫疾患診断市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Autoimmune Disease Diagnostics Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z0519
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、133ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品、ヘルスケア

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、自己免疫疾患診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（分析装置、アッセイキット）、用途別市場規模（病院、診断・研究所）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・自己免疫疾患診断の市場動向
・企業の競争状況、市場シェア
・自己免疫疾患診断の種類別市場規模（分析装置、アッセイキット）
・自己免疫疾患診断の用途別市場規模（病院、診断・研究所）
・自己免疫疾患診断の北米市場規模2016-2027（アメリカ、カナダ）
・自己免疫疾患診断のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・自己免疫疾患診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・自己免疫疾患診断の中南米市場規模2016-2027（メキシコ、ブラジル）
・自己免疫疾患診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Abbott Laboratories、Beckman Coulter、Bio-Rad Laboratories、EUROIMMUN、Inova Diagnostics、Roche Diagnostics、Siemens Healthcare、DiaSorin、ERBA Diagnostics、Euro Diagnostica、Autoimmune Technologies、Avant Diagnostics、Exagen Diagnostics、Gold Standard Diagnostics、HOB Diagnostics、HUMAN Diagnostics、Immco Diagnostics、ImmunArray、Myriad Genetics、Omega Diagnostics、ORGENTEC Diagnostika、Phadia、Protagen）
・結論

The diagnosis of autoimmune diseases depends on the identification of disease-associated clinical symptoms and is associated with the detection of autoantibodies. Clinicians conventionally classify autoimmune diseases as either systemic or organ-specific.
In terms of geography, the Americas led the global autoimmune disease diagnostics market and will continue to dominate the market in the coming years. The growing incidence of autoimmune disorders such as RA, SLE, and IBD will aid in the growth of this market. Also, the extensive R&D activities has allowed the launch of novel diagnostic products, which are expected to drive the adoption rates for autoimmune diagnostics in the Americas.

Market Analysis and Insights: Global Autoimmune Disease Diagnostics Market
The global Autoimmune Disease Diagnostics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Autoimmune Disease Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Autoimmune Disease Diagnostics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Autoimmune Disease Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Autoimmune Disease Diagnostics market.

Global Autoimmune Disease Diagnostics Scope and Market Size
Autoimmune Disease Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Autoimmune Disease Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Analyzers
Assay Kits

Segment by Application
Hospitals
Diagnostic and Research Laboratories

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbott Laboratories
Beckman Coulter
Bio-Rad Laboratories
EUROIMMUN
Inova Diagnostics
Roche Diagnostics
Siemens Healthcare
DiaSorin
ERBA Diagnostics
EUROIMMUN
Inova Diagnostics
Avant Diagnostics
Exagen Diagnostics
Gold Standard Diagnostics
HOB Diagnostics
HUMAN Diagnostics
Immco Diagnostics
ImmunArray
Myriad Genetics
Omega Diagnostics
ORGENTEC Diagnostika

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Autoimmune Disease Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Analyzers
1.2.3 Assay Kits
1.3 Market by Application
1.3.1 Global Autoimmune Disease Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Diagnostic and Research Laboratories
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Autoimmune Disease Diagnostics Market Perspective (2016-2027)
2.2 Autoimmune Disease Diagnostics Growth Trends by Regions
2.2.1 Autoimmune Disease Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Autoimmune Disease Diagnostics Historic Market Share by Regions (2016-2021)
2.2.3 Autoimmune Disease Diagnostics Forecasted Market Size by Regions (2022-2027)
2.3 Autoimmune Disease Diagnostics Industry Dynamic
2.3.1 Autoimmune Disease Diagnostics Market Trends
2.3.2 Autoimmune Disease Diagnostics Market Drivers
2.3.3 Autoimmune Disease Diagnostics Market Challenges
2.3.4 Autoimmune Disease Diagnostics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Autoimmune Disease Diagnostics Players by Revenue
3.1.1 Global Top Autoimmune Disease Diagnostics Players by Revenue (2016-2021)
3.1.2 Global Autoimmune Disease Diagnostics Revenue Market Share by Players (2016-2021)
3.2 Global Autoimmune Disease Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Autoimmune Disease Diagnostics Revenue
3.4 Global Autoimmune Disease Diagnostics Market Concentration Ratio
3.4.1 Global Autoimmune Disease Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Autoimmune Disease Diagnostics Revenue in 2020
3.5 Autoimmune Disease Diagnostics Key Players Head office and Area Served
3.6 Key Players Autoimmune Disease Diagnostics Product Solution and Service
3.7 Date of Enter into Autoimmune Disease Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Autoimmune Disease Diagnostics Breakdown Data by Type
4.1 Global Autoimmune Disease Diagnostics Historic Market Size by Type (2016-2021)
4.2 Global Autoimmune Disease Diagnostics Forecasted Market Size by Type (2022-2027)

5 Autoimmune Disease Diagnostics Breakdown Data by Application
5.1 Global Autoimmune Disease Diagnostics Historic Market Size by Application (2016-2021)
5.2 Global Autoimmune Disease Diagnostics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Autoimmune Disease Diagnostics Market Size (2016-2027)
6.2 North America Autoimmune Disease Diagnostics Market Size by Type
6.2.1 North America Autoimmune Disease Diagnostics Market Size by Type (2016-2021)
6.2.2 North America Autoimmune Disease Diagnostics Market Size by Type (2022-2027)
6.2.3 North America Autoimmune Disease Diagnostics Market Size by Type (2016-2027)
6.3 North America Autoimmune Disease Diagnostics Market Size by Application
6.3.1 North America Autoimmune Disease Diagnostics Market Size by Application (2016-2021)
6.3.2 North America Autoimmune Disease Diagnostics Market Size by Application (2022-2027)
6.3.3 North America Autoimmune Disease Diagnostics Market Size by Application (2016-2027)
6.4 North America Autoimmune Disease Diagnostics Market Size by Country
6.4.1 North America Autoimmune Disease Diagnostics Market Size by Country (2016-2021)
6.4.2 North America Autoimmune Disease Diagnostics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Autoimmune Disease Diagnostics Market Size (2016-2027)
7.2 Europe Autoimmune Disease Diagnostics Market Size by Type
7.2.1 Europe Autoimmune Disease Diagnostics Market Size by Type (2016-2021)
7.2.2 Europe Autoimmune Disease Diagnostics Market Size by Type (2022-2027)
7.2.3 Europe Autoimmune Disease Diagnostics Market Size by Type (2016-2027)
7.3 Europe Autoimmune Disease Diagnostics Market Size by Application
7.3.1 Europe Autoimmune Disease Diagnostics Market Size by Application (2016-2021)
7.3.2 Europe Autoimmune Disease Diagnostics Market Size by Application (2022-2027)
7.3.3 Europe Autoimmune Disease Diagnostics Market Size by Application (2016-2027)
7.4 Europe Autoimmune Disease Diagnostics Market Size by Country
7.4.1 Europe Autoimmune Disease Diagnostics Market Size by Country (2016-2021)
7.4.2 Europe Autoimmune Disease Diagnostics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Autoimmune Disease Diagnostics Market Size (2016-2027)
8.2 Asia-Pacific Autoimmune Disease Diagnostics Market Size by Type
8.2.1 Asia-Pacific Autoimmune Disease Diagnostics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Autoimmune Disease Diagnostics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Autoimmune Disease Diagnostics Market Size by Type (2016-2027)
8.3 Asia-Pacific Autoimmune Disease Diagnostics Market Size by Application
8.3.1 Asia-Pacific Autoimmune Disease Diagnostics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Autoimmune Disease Diagnostics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Autoimmune Disease Diagnostics Market Size by Application (2016-2027)
8.4 Asia-Pacific Autoimmune Disease Diagnostics Market Size by Region
8.4.1 Asia-Pacific Autoimmune Disease Diagnostics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Autoimmune Disease Diagnostics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Autoimmune Disease Diagnostics Market Size (2016-2027)
9.2 Latin America Autoimmune Disease Diagnostics Market Size by Type
9.2.1 Latin America Autoimmune Disease Diagnostics Market Size by Type (2016-2021)
9.2.2 Latin America Autoimmune Disease Diagnostics Market Size by Type (2022-2027)
9.2.3 Latin America Autoimmune Disease Diagnostics Market Size by Type (2016-2027)
9.3 Latin America Autoimmune Disease Diagnostics Market Size by Application
9.3.1 Latin America Autoimmune Disease Diagnostics Market Size by Application (2016-2021)
9.3.2 Latin America Autoimmune Disease Diagnostics Market Size by Application (2022-2027)
9.3.3 Latin America Autoimmune Disease Diagnostics Market Size by Application (2016-2027)
9.4 Latin America Autoimmune Disease Diagnostics Market Size by Country
9.4.1 Latin America Autoimmune Disease Diagnostics Market Size by Country (2016-2021)
9.4.2 Latin America Autoimmune Disease Diagnostics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Autoimmune Disease Diagnostics Market Size (2016-2027)
10.2 Middle East & Africa Autoimmune Disease Diagnostics Market Size by Type
10.2.1 Middle East & Africa Autoimmune Disease Diagnostics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Autoimmune Disease Diagnostics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Autoimmune Disease Diagnostics Market Size by Type (2016-2027)
10.3 Middle East & Africa Autoimmune Disease Diagnostics Market Size by Application
10.3.1 Middle East & Africa Autoimmune Disease Diagnostics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Autoimmune Disease Diagnostics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Autoimmune Disease Diagnostics Market Size by Application (2016-2027)
10.4 Middle East & Africa Autoimmune Disease Diagnostics Market Size by Country
10.4.1 Middle East & Africa Autoimmune Disease Diagnostics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Autoimmune Disease Diagnostics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Autoimmune Disease Diagnostics Introduction
11.1.4 Abbott Laboratories Revenue in Autoimmune Disease Diagnostics Business (2016-2021)
11.1.5 Abbott Laboratories Recent Development
11.2 Beckman Coulter
11.2.1 Beckman Coulter Company Details
11.2.2 Beckman Coulter Business Overview
11.2.3 Beckman Coulter Autoimmune Disease Diagnostics Introduction
11.2.4 Beckman Coulter Revenue in Autoimmune Disease Diagnostics Business (2016-2021)
11.2.5 Beckman Coulter Recent Development
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Details
11.3.2 Bio-Rad Laboratories Business Overview
11.3.3 Bio-Rad Laboratories Autoimmune Disease Diagnostics Introduction
11.3.4 Bio-Rad Laboratories Revenue in Autoimmune Disease Diagnostics Business (2016-2021)
11.3.5 Bio-Rad Laboratories Recent Development
11.4 EUROIMMUN
11.4.1 EUROIMMUN Company Details
11.4.2 EUROIMMUN Business Overview
11.4.3 EUROIMMUN Autoimmune Disease Diagnostics Introduction
11.4.4 EUROIMMUN Revenue in Autoimmune Disease Diagnostics Business (2016-2021)
11.4.5 EUROIMMUN Recent Development
11.5 Inova Diagnostics
11.5.1 Inova Diagnostics Company Details
11.5.2 Inova Diagnostics Business Overview
11.5.3 Inova Diagnostics Autoimmune Disease Diagnostics Introduction
11.5.4 Inova Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2016-2021)
11.5.5 Inova Diagnostics Recent Development
11.6 Roche Diagnostics
11.6.1 Roche Diagnostics Company Details
11.6.2 Roche Diagnostics Business Overview
11.6.3 Roche Diagnostics Autoimmune Disease Diagnostics Introduction
11.6.4 Roche Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2016-2021)
11.6.5 Roche Diagnostics Recent Development
11.7 Siemens Healthcare
11.7.1 Siemens Healthcare Company Details
11.7.2 Siemens Healthcare Business Overview
11.7.3 Siemens Healthcare Autoimmune Disease Diagnostics Introduction
11.7.4 Siemens Healthcare Revenue in Autoimmune Disease Diagnostics Business (2016-2021)
11.7.5 Siemens Healthcare Recent Development
11.8 DiaSorin
11.8.1 DiaSorin Company Details
11.8.2 DiaSorin Business Overview
11.8.3 DiaSorin Autoimmune Disease Diagnostics Introduction
11.8.4 DiaSorin Revenue in Autoimmune Disease Diagnostics Business (2016-2021)
11.8.5 DiaSorin Recent Development
11.9 ERBA Diagnostics
11.9.1 ERBA Diagnostics Company Details
11.9.2 ERBA Diagnostics Business Overview
11.9.3 ERBA Diagnostics Autoimmune Disease Diagnostics Introduction
11.9.4 ERBA Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2016-2021)
11.9.5 ERBA Diagnostics Recent Development
11.10 Euro Diagnostica
11.10.1 Euro Diagnostica Company Details
11.10.2 Euro Diagnostica Business Overview
11.10.3 Euro Diagnostica Autoimmune Disease Diagnostics Introduction
11.10.4 Euro Diagnostica Revenue in Autoimmune Disease Diagnostics Business (2016-2021)
11.10.5 Euro Diagnostica Recent Development
11.11 Autoimmune Technologies
11.11.1 Autoimmune Technologies Company Details
11.11.2 Autoimmune Technologies Business Overview
11.11.3 Autoimmune Technologies Autoimmune Disease Diagnostics Introduction
11.11.4 Autoimmune Technologies Revenue in Autoimmune Disease Diagnostics Business (2016-2021)
11.11.5 Autoimmune Technologies Recent Development
11.12 Avant Diagnostics
11.12.1 Avant Diagnostics Company Details
11.12.2 Avant Diagnostics Business Overview
11.12.3 Avant Diagnostics Autoimmune Disease Diagnostics Introduction
11.12.4 Avant Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2016-2021)
11.12.5 Avant Diagnostics Recent Development
11.13 Exagen Diagnostics
11.13.1 Exagen Diagnostics Company Details
11.13.2 Exagen Diagnostics Business Overview
11.13.3 Exagen Diagnostics Autoimmune Disease Diagnostics Introduction
11.13.4 Exagen Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2016-2021)
11.13.5 Exagen Diagnostics Recent Development
11.14 Gold Standard Diagnostics
11.14.1 Gold Standard Diagnostics Company Details
11.14.2 Gold Standard Diagnostics Business Overview
11.14.3 Gold Standard Diagnostics Autoimmune Disease Diagnostics Introduction
11.14.4 Gold Standard Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2016-2021)
11.14.5 Gold Standard Diagnostics Recent Development
11.15 HOB Diagnostics
11.15.1 HOB Diagnostics Company Details
11.15.2 HOB Diagnostics Business Overview
11.15.3 HOB Diagnostics Autoimmune Disease Diagnostics Introduction
11.15.4 HOB Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2016-2021)
11.15.5 HOB Diagnostics Recent Development
11.16 HUMAN Diagnostics
11.16.1 HUMAN Diagnostics Company Details
11.16.2 HUMAN Diagnostics Business Overview
11.16.3 HUMAN Diagnostics Autoimmune Disease Diagnostics Introduction
11.16.4 HUMAN Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2016-2021)
11.16.5 HUMAN Diagnostics Recent Development
11.17 Immco Diagnostics
11.17.1 Immco Diagnostics Company Details
11.17.2 Immco Diagnostics Business Overview
11.17.3 Immco Diagnostics Autoimmune Disease Diagnostics Introduction
11.17.4 Immco Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2016-2021)
11.17.5 Immco Diagnostics Recent Development
11.18 ImmunArray
11.18.1 ImmunArray Company Details
11.18.2 ImmunArray Business Overview
11.18.3 ImmunArray Autoimmune Disease Diagnostics Introduction
11.18.4 ImmunArray Revenue in Autoimmune Disease Diagnostics Business (2016-2021)
11.18.5 ImmunArray Recent Development
11.18 Myriad Genetics
.1 Myriad Genetics Company Details
.2 Myriad Genetics Business Overview
.3 Myriad Genetics Autoimmune Disease Diagnostics Introduction
.4 Myriad Genetics Revenue in Autoimmune Disease Diagnostics Business (2016-2021)
.5 Myriad Genetics Recent Development
11.20 Omega Diagnostics
11.20.1 Omega Diagnostics Company Details
11.20.2 Omega Diagnostics Business Overview
11.20.3 Omega Diagnostics Autoimmune Disease Diagnostics Introduction
11.20.4 Omega Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2016-2021)
11.20.5 Omega Diagnostics Recent Development
11.21 ORGENTEC Diagnostika
11.21.1 ORGENTEC Diagnostika Company Details
11.21.2 ORGENTEC Diagnostika Business Overview
11.21.3 ORGENTEC Diagnostika Autoimmune Disease Diagnostics Introduction
11.21.4 ORGENTEC Diagnostika Revenue in Autoimmune Disease Diagnostics Business (2016-2021)
11.21.5 ORGENTEC Diagnostika Recent Development
11.22 Phadia
11.22.1 Phadia Company Details
11.22.2 Phadia Business Overview
11.22.3 Phadia Autoimmune Disease Diagnostics Introduction
11.22.4 Phadia Revenue in Autoimmune Disease Diagnostics Business (2016-2021)
11.22.5 Phadia Recent Development
11.23 Protagen
11.23.1 Protagen Company Details
11.23.2 Protagen Business Overview
11.23.3 Protagen Autoimmune Disease Diagnostics Introduction
11.23.4 Protagen Revenue in Autoimmune Disease Diagnostics Business (2016-2021)
11.23.5 Protagen Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Autoimmune Disease Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Analyzers
Table 3. Key Players of Assay Kits
Table 4. Global Autoimmune Disease Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Autoimmune Disease Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Autoimmune Disease Diagnostics Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Autoimmune Disease Diagnostics Market Share by Regions (2016-2021)
Table 8. Global Autoimmune Disease Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Autoimmune Disease Diagnostics Market Share by Regions (2022-2027)
Table 10. Autoimmune Disease Diagnostics Market Trends
Table 11. Autoimmune Disease Diagnostics Market Drivers
Table 12. Autoimmune Disease Diagnostics Market Challenges
Table 13. Autoimmune Disease Diagnostics Market Restraints
Table 14. Global Autoimmune Disease Diagnostics Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Autoimmune Disease Diagnostics Market Share by Players (2016-2021)
Table 16. Global Top Autoimmune Disease Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Autoimmune Disease Diagnostics as of 2020)
Table 17. Ranking of Global Top Autoimmune Disease Diagnostics Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Autoimmune Disease Diagnostics Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Autoimmune Disease Diagnostics Product Solution and Service
Table 21. Date of Enter into Autoimmune Disease Diagnostics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Autoimmune Disease Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Autoimmune Disease Diagnostics Revenue Market Share by Type (2016-2021)
Table 25. Global Autoimmune Disease Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Autoimmune Disease Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Autoimmune Disease Diagnostics Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Autoimmune Disease Diagnostics Revenue Market Share by Application (2016-2021)
Table 29. Global Autoimmune Disease Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Autoimmune Disease Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Autoimmune Disease Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Autoimmune Disease Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Autoimmune Disease Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Autoimmune Disease Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Autoimmune Disease Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Autoimmune Disease Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Autoimmune Disease Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Autoimmune Disease Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Autoimmune Disease Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Autoimmune Disease Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Autoimmune Disease Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Autoimmune Disease Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Autoimmune Disease Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Autoimmune Disease Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Autoimmune Disease Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Autoimmune Disease Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Autoimmune Disease Diagnostics Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Autoimmune Disease Diagnostics Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Autoimmune Disease Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Autoimmune Disease Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Autoimmune Disease Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Autoimmune Disease Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Autoimmune Disease Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Autoimmune Disease Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Autoimmune Disease Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Autoimmune Disease Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Autoimmune Disease Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Autoimmune Disease Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Autoimmune Disease Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Autoimmune Disease Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 61. Abbott Laboratories Company Details
Table 62. Abbott Laboratories Business Overview
Table 63. Abbott Laboratories Autoimmune Disease Diagnostics Product
Table 64. Abbott Laboratories Revenue in Autoimmune Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 65. Abbott Laboratories Recent Development
Table 66. Beckman Coulter Company Details
Table 67. Beckman Coulter Business Overview
Table 68. Beckman Coulter Autoimmune Disease Diagnostics Product
Table 69. Beckman Coulter Revenue in Autoimmune Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 70. Beckman Coulter Recent Development
Table 71. Bio-Rad Laboratories Company Details
Table 72. Bio-Rad Laboratories Business Overview
Table 73. Bio-Rad Laboratories Autoimmune Disease Diagnostics Product
Table 74. Bio-Rad Laboratories Revenue in Autoimmune Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 75. Bio-Rad Laboratories Recent Development
Table 76. EUROIMMUN Company Details
Table 77. EUROIMMUN Business Overview
Table 78. EUROIMMUN Autoimmune Disease Diagnostics Product
Table 79. EUROIMMUN Revenue in Autoimmune Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 80. EUROIMMUN Recent Development
Table 81. Inova Diagnostics Company Details
Table 82. Inova Diagnostics Business Overview
Table 83. Inova Diagnostics Autoimmune Disease Diagnostics Product
Table 84. Inova Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 85. Inova Diagnostics Recent Development
Table 86. Roche Diagnostics Company Details
Table 87. Roche Diagnostics Business Overview
Table 88. Roche Diagnostics Autoimmune Disease Diagnostics Product
Table 89. Roche Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 90. Roche Diagnostics Recent Development
Table 91. Siemens Healthcare Company Details
Table 92. Siemens Healthcare Business Overview
Table 93. Siemens Healthcare Autoimmune Disease Diagnostics Product
Table 94. Siemens Healthcare Revenue in Autoimmune Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 95. Siemens Healthcare Recent Development
Table 96. DiaSorin Company Details
Table 97. DiaSorin Business Overview
Table 98. DiaSorin Revenue in Autoimmune Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 99. DiaSorin Recent Development
Table 100. ERBA Diagnostics Company Details
Table 101. ERBA Diagnostics Business Overview
Table 102. ERBA Diagnostics Autoimmune Disease Diagnostics Product
Table 103. ERBA Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 104. ERBA Diagnostics Recent Development
Table 105. Euro Diagnostica Company Details
Table 106. Euro Diagnostica Business Overview
Table 107. Euro Diagnostica Autoimmune Disease Diagnostics Product
Table 108. Euro Diagnostica Revenue in Autoimmune Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 109. Euro Diagnostica Recent Development
Table 110. Autoimmune Technologies Company Details
Table 111. Autoimmune Technologies Business Overview
Table 112. Autoimmune Technologies Autoimmune Disease Diagnostics Product
Table 113. Autoimmune Technologies Revenue in Autoimmune Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 114. Autoimmune Technologies Recent Development
Table 115. Avant Diagnostics Company Details
Table 116. Avant Diagnostics Business Overview
Table 117. Avant Diagnostics Autoimmune Disease Diagnostics Product
Table 118. Avant Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 119. Avant Diagnostics Recent Development
Table 120. Exagen Diagnostics Company Details
Table 121. Exagen Diagnostics Business Overview
Table 122. Exagen Diagnostics Autoimmune Disease Diagnostics Product
Table 123. Exagen Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 124. Exagen Diagnostics Recent Development
Table 125. Gold Standard Diagnostics Company Details
Table 126. Gold Standard Diagnostics Business Overview
Table 127. Gold Standard Diagnostics Autoimmune Disease Diagnostics Product
Table 128. Gold Standard Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 129. Gold Standard Diagnostics Recent Development
Table 130. HOB Diagnostics Company Details
Table 131. HOB Diagnostics Business Overview
Table 132. HOB Diagnostics Autoimmune Disease Diagnostics Product
Table 133. HOB Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 134. HOB Diagnostics Recent Development
Table 135. HUMAN Diagnostics Company Details
Table 136. HUMAN Diagnostics Business Overview
Table 137. HUMAN Diagnostics Autoimmune Disease Diagnostics Product
Table 138. HUMAN Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 139. HUMAN Diagnostics Recent Development
Table 140. Immco Diagnostics Company Details
Table 141. Immco Diagnostics Business Overview
Table 142. Immco Diagnostics Autoimmune Disease Diagnostics Product
Table 143. Immco Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 144. Immco Diagnostics Recent Development
Table 145. ImmunArray Company Details
Table 146. ImmunArray Business Overview
Table 147. ImmunArray Autoimmune Disease Diagnostics Product
Table 148. ImmunArray Revenue in Autoimmune Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 149. ImmunArray Recent Development
Table 150. Myriad Genetics Company Details
Table 151. Myriad Genetics Business Overview
Table 152. Myriad Genetics Autoimmune Disease Diagnostics Product
Table 153. Myriad Genetics Revenue in Autoimmune Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 154. Myriad Genetics Recent Development
Table 155. Omega Diagnostics Company Details
Table 156. Omega Diagnostics Business Overview
Table 157. Omega Diagnostics Autoimmune Disease Diagnostics Product
Table 158. Omega Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 159. Omega Diagnostics Recent Development
Table 160. ORGENTEC Diagnostika Company Details
Table 161. ORGENTEC Diagnostika Business Overview
Table 162. ORGENTEC Diagnostika Autoimmune Disease Diagnostics Product
Table 163. ORGENTEC Diagnostika Revenue in Autoimmune Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 164. ORGENTEC Diagnostika Recent Development
Table 165. Phadia Company Details
Table 166. Phadia Business Overview
Table 167. Phadia Autoimmune Disease Diagnostics Product
Table 168. Phadia Revenue in Autoimmune Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 169. Phadia Recent Development
Table 170. Protagen Company Details
Table 171. Protagen Business Overview
Table 172. Protagen Autoimmune Disease Diagnostics Product
Table 173. Protagen Revenue in Autoimmune Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 174. Protagen Recent Development
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Autoimmune Disease Diagnostics Market Share by Type: 2020 VS 2027
Figure 2. Analyzers Features
Figure 3. Assay Kits Features
Figure 4. Global Autoimmune Disease Diagnostics Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Diagnostic and Research Laboratories Case Studies
Figure 7. Autoimmune Disease Diagnostics Report Years Considered
Figure 8. Global Autoimmune Disease Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Autoimmune Disease Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Autoimmune Disease Diagnostics Market Share by Regions: 2020 VS 2027
Figure 11. Global Autoimmune Disease Diagnostics Market Share by Regions (2022-2027)
Figure 12. Global Autoimmune Disease Diagnostics Market Share by Players in 2020
Figure 13. Global Top Autoimmune Disease Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Autoimmune Disease Diagnostics as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Autoimmune Disease Diagnostics Revenue in 2020
Figure 15. Global Autoimmune Disease Diagnostics Revenue Market Share by Type (2016-2021)
Figure 16. Global Autoimmune Disease Diagnostics Revenue Market Share by Type (2022-2027)
Figure 17. North America Autoimmune Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Autoimmune Disease Diagnostics Market Share by Type (2016-2027)
Figure 19. North America Autoimmune Disease Diagnostics Market Share by Application (2016-2027)
Figure 20. North America Autoimmune Disease Diagnostics Market Share by Country (2016-2027)
Figure 21. United States Autoimmune Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Autoimmune Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Autoimmune Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Autoimmune Disease Diagnostics Market Share by Type (2016-2027)
Figure 25. Europe Autoimmune Disease Diagnostics Market Share by Application (2016-2027)
Figure 26. Europe Autoimmune Disease Diagnostics Market Share by Country (2016-2027)
Figure 27. Germany Autoimmune Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Autoimmune Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Autoimmune Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Autoimmune Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Autoimmune Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Autoimmune Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Autoimmune Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Autoimmune Disease Diagnostics Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Autoimmune Disease Diagnostics Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Autoimmune Disease Diagnostics Market Share by Region (2016-2027)
Figure 37. China Autoimmune Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Autoimmune Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Autoimmune Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Autoimmune Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Autoimmune Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Autoimmune Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Autoimmune Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Autoimmune Disease Diagnostics Market Share by Type (2016-2027)
Figure 45. Latin America Autoimmune Disease Diagnostics Market Share by Application (2016-2027)
Figure 46. Latin America Autoimmune Disease Diagnostics Market Share by Country (2016-2027)
Figure 47. Mexico Autoimmune Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Autoimmune Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Autoimmune Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Autoimmune Disease Diagnostics Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Autoimmune Disease Diagnostics Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Autoimmune Disease Diagnostics Market Share by Country (2016-2027)
Figure 53. Turkey Autoimmune Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Autoimmune Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Autoimmune Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Abbott Laboratories Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2016-2021)
Figure 57. Beckman Coulter Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2016-2021)
Figure 58. Bio-Rad Laboratories Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2016-2021)
Figure 59. EUROIMMUN Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2016-2021)
Figure 60. Inova Diagnostics Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2016-2021)
Figure 61. Roche Diagnostics Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2016-2021)
Figure 62. Siemens Healthcare Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2016-2021)
Figure 63. DiaSorin Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2016-2021)
Figure 64. ERBA Diagnostics Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2016-2021)
Figure 65. Euro Diagnostica Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2016-2021)
Figure 66. Autoimmune Technologies Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2016-2021)
Figure 67. Avant Diagnostics Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2016-2021)
Figure 68. Exagen Diagnostics Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2016-2021)
Figure 69. Gold Standard Diagnostics Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2016-2021)
Figure 70. HOB Diagnostics Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2016-2021)
Figure 71. HUMAN Diagnostics Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2016-2021)
Figure 72. Immco Diagnostics Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2016-2021)
Figure 73. ImmunArray Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2016-2021)
Figure 74. Myriad Genetics Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2016-2021)
Figure 75. Omega Diagnostics Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2016-2021)
Figure 76. ORGENTEC Diagnostika Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2016-2021)
Figure 77. Phadia Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2016-2021)
Figure 78. Protagen Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2016-2021)
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed

以下、関連資料のご紹介

世界の自己免疫疾患診断市場規模・現状・予測（2021年-2027年）

Global Autoimmune Disease Diagnosis Market Size, Status and Forecast 2021-2027
QYR2104Z0518 2021年4月 98Pages
QYResearch社発行の本調査資料では、自己免疫疾患診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（定期検査、炎症マーカー、自己抗体・免疫学的検査、その他検査）、用途別市場規模（臨床検査室、病院、その他エンドユーザー）、主要地域別市場規...

世界の自己免疫疾患治療市場規模・現状・予測（2021年-2027年）

Global Autoimmune Disease Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z0520 2021年4月 93Pages
QYResearch社発行の本調査資料では、自己免疫疾患治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（免疫抑制剤、抗炎症薬、コルチコステロイド、非ステロイド性抗炎症薬、生物製剤、その他）、用途別市場規模（病院、クリニック、独立型薬局、その...

世界の自己免疫疾患治療市場規模・現状・予測（2021年-2027年）

Global Autoimmune Disease Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0521 2021年4月 125Pages
QYResearch社発行の本調査資料では、自己免疫疾患治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（免疫抑制剤、抗炎症薬、コルチコステロイド、非ステロイド性抗炎症薬、生物製剤）、用途別市場規模（病院、クリニック、ドラッグストア、その他）...

世界の全身性自己免疫疾患診断市場 2021：企業別、地域別、種類・用途別

Global Systemic Autoimmune Disease Diagnostics Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-2104Z13582 2021年4月 106Pages
当調査資料では、全身性自己免疫疾患診断のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。全身性自己免疫疾患診断の種類別市場規模（関節リウマチ、強直性脊椎炎、全身性エリテマトーデス（SLE）、その他）、用途別市場規模（病院、診療所、研究所、実験室）、地域別...

世界の限局性自己免疫疾患診断市場 2021：企業別、地域別、種類・用途別

Global Localized Autoimmune Disease Diagnostics Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-2104Z08512 2021年4月 107Pages
当調査資料では、限局性自己免疫疾患診断のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。限局性自己免疫疾患診断の種類別市場規模（多発性硬化症、1型糖尿病、橋本甲状腺炎、特発性血小板減少性紫斑病、その他）、用途別市場規模（病院、診療所、研究所、実験室）、地...

世界の自己免疫疾患用体外診断用医薬品（IVD）・薬事未承認検査市場規模・現状・予測（2021年-2027年）

Global In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Size, Status and Forecast 2021-2027
QYR2104Z3067 2021年4月 92Pages
QYResearch社発行の本調査資料では、自己免疫疾患用体外診断用医薬品（IVD）・薬事未承認検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（試薬・キット、機器、サービス、データ管理ソフトウェア）、用途別市場規模（糖尿病、感染症、腫瘍・癌...

世界の感染症診断市場規模・現状・予測（2021年-2027年）

Global Infectious Disease Diagnostics Market Size, Status and Forecast 2021-2027
QYR2104Z3140 2021年4月 95Pages
QYResearch社発行の本調査資料では、感染症診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（分子診断技術、従来型診断技術）、用途別市場規模（C型肝炎、B型肝炎、結核（TB）、後天性免疫不全症候群（AIDS）、ヒトパピローマウイルス（H...

世界のアルツハイマー病治療・診断市場規模・現状・予測（2021年-2027年）

Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size, Status and Forecast 2021-2027
QYR2104Z0275 2021年4月 91Pages
QYResearch社発行の本調査資料では、アルツハイマー病治療・診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（腰椎穿刺検査、コンピューター断層撮影（CT）スキャン、磁気共鳴画像（MRI）、脳波（EEG）、ポジトロン放出断層撮影（PET）...

世界の自己免疫疾患治療市場規模・現状・予測（2021年-2027年）

Global Autoimmune Disorders Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0523 2021年4月 91Pages
QYResearch社発行の本調査資料では、自己免疫疾患治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ブリッジ療法、組換え技術、糞便細菌療法、造血幹細胞移植、光線療法、寄生虫療法、活性化誘導アッセイ、飛行時間型質量分析サイトメトリー）、用...

世界のアルツハイマー病治療・診断市場規模・現状・予測（2021年-2027年）

Global Alzheimer's Disease Therapeutics and Diagnostics Market Size, Status and Forecast 2021-2027
QYR2104Z0278 2021年4月 91Pages
QYResearch社発行の本調査資料では、アルツハイマー病治療・診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（バイオマーカー、コリンエステラーゼ阻害剤、NMDA受容体拮抗薬、脳イメージング、血液検査）、用途別市場規模（医薬品市場、診断市...

世界の自己免疫疾患診断市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Autoimmune Disease Diagnosis Market The global Autoimmune Disease Diagnosis market size is projected to reach US$ 4227.9 million by 2026, from US$ 2983.8 million in 2019, at a CAGR of 5.0% during 2021-2026. With industry-standard accuracy in analysis and high dat…
世界の全身性自己免疫疾患診断市場 2021：企業別、地域別、種類・用途別 The Systemic Autoimmune Disease Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizatio…
世界の限局性自己免疫疾患診断市場 2021：企業別、地域別、種類・用途別 The Localized Autoimmune Disease Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizati…
世界の自己免疫疾患治療市場規模・現状・予測（2021年-2027年） Autoimmune diseases is a body’s hyperactive immune response against the substances and tissues normally present in the body. Autoimmune diseases are more commonly caused by genetic, infectious or environmental factors. Market Analysis and Insights: Global Autoimmune Disease Treatment Market The glob…
世界の自己免疫疾患治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Autoimmune Disease Therapeutics Market The global Autoimmune Disease Therapeutics market size is projected to reach US$ 116550 million by 2026, from US$ 98660 million in 2019, at a CAGR of 2.4% during 2021-2026. With industry-standard accuracy in analysis and hig…